ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0596

Neutrophil Extracellular Traps (NET) Trigger an Enhanced Pro-inflammatory Response in Macrophage Subpopulations in Rheumatoid Arthritis Patients via the Aryl Hydrocarbon Receptor (AhR) Pathway

Dyhia Melbouci1, Sarra Seninet1, Marie-Christophe Boissier2, Elodie Segura3 and Patrice Decker1, 1University Sorbonne Paris Nord, Inserm UMR 1125, Li2P, Bobigny, France, 2INSERM UMR 1125, Sorbonne Paris Nord University,Rheumatology Dpt, APHP, GHUPSSD, Avicenne Hosp, Bobigny, France, 3U932 Inserm, Curie Institute, Paris, France

Meeting: ACR Convergence 2022

Keywords: cytokines, Inflammation, macrophages, neutrophils, rheumatoid arthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 13, 2022

Title: RA – Etiology and Pathogenesis Poster

Session Type: Poster Session B

Session Time: 9:00AM-10:30AM

Background/Purpose: Activated neutrophils (PMN) form neutrophil extracellular traps (NET), fibers of DNA and associated proteins expelled in the extracellular space. Increased NET formation has been reported in rheumatoid arthritis (RA). Moreover, macrophages play a key role in RA pathogenesis. We have previously shown that NET are pro-inflammatory on resting non-polarized macrophages, whereas NET partly inhibit the response of LPS-stimulated macrophages (Ribon et al., J. Autoimmun, 2019, 98:122). We now aimed to characterize inflammatory properties of NET on polarized macrophage sub-populations in RA in comparison to healthy donors (HD) and to determine the mechanisms and pathways involved.

Methods: Primary blood PMN/monocytes were freshly purified from HD and RA patients. Monocytes were differentiated into non-polarized (M0), anti-inflammatory (M2a, M2c) or pro-inflammatory (M1) macrophages with cytokines. NET were induced in vitro by stimulating PMN with PMA and characterized. Mouse (wild-type, TLR9-deficient or C1q-deficient) bone marrow cells were used to differentiate macrophages and to prepare NET from purified PMN. Macrophages were cultured with NET in the presence/absence of LPS or an aryl hydrocarbon receptor (AhR) antagonist. Cell purity, phenotype and activation were estimated by flow cytometry. Cytokine secretion was measured by ELISA. The pathway triggered was estimated by bulk RNA-seq. Gene expression was confirmed by qRT-PCR.

Results: All resting macrophage subpopulations were activated by NET, leading to a pro-inflammatory response. The pro-inflammatory cytokine IL-8 was secreted, whereas secretion of the immunomodulatory IL-10 was minimal. Even M2 macrophages were activated toward this pro-inflammatory profile, with a stronger response in RA patients. In response to LPS, NET inhibit IL-6 secretion in HD macrophages whereas RA M1 and M2a macrophages were resistant to this anti-inflammatory activity of NET. Moreover, RA M1 macrophages produce more IL-8. In mouse macrophages, TLR9 is not involved in NET recognition. Moreover, C1q loaded on NET is not necessary to trigger macrophage activation. RNA-sequencing confirmed the induction of pro-inflammatory mediators, whereas IL-10 was down-regulated, and suggested that the AhR pathway is involved in macrophages in response to NET via CYP1A1 induction. Triggering of the AhR pathway by NET was next confirmed by culturing M1 macrophages with RA NET in the presence of an AhR antagonist, which showed inhibition of CYP1A1 expression.

Conclusion: Pro-inflammatory activities of NET clearly dominate anti-inflammatory activities in macrophages, particularly in RA patients, suggesting a pathogenic role of NET in RA by inducing a pro-inflammatory response of macrophages through AhR.


Disclosures: D. Melbouci, None; S. Seninet, None; M. Boissier, None; E. Segura, None; P. Decker, None.

To cite this abstract in AMA style:

Melbouci D, Seninet S, Boissier M, Segura E, Decker P. Neutrophil Extracellular Traps (NET) Trigger an Enhanced Pro-inflammatory Response in Macrophage Subpopulations in Rheumatoid Arthritis Patients via the Aryl Hydrocarbon Receptor (AhR) Pathway [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/neutrophil-extracellular-traps-net-trigger-an-enhanced-pro-inflammatory-response-in-macrophage-subpopulations-in-rheumatoid-arthritis-patients-via-the-aryl-hydrocarbon-receptor-ahr-pathway/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/neutrophil-extracellular-traps-net-trigger-an-enhanced-pro-inflammatory-response-in-macrophage-subpopulations-in-rheumatoid-arthritis-patients-via-the-aryl-hydrocarbon-receptor-ahr-pathway/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology